LATEST ALERTS
Imperial Brands has announced that it expects to deliver its yearly objectives for 2021 and expressed optimism about the performance of its heated tobacco device Pulze
PMI is spreading optimism about its “beyond nicotine” portfolio, aiming to reach $1bn revenue from tobacco-alternatives in less than five years’ time, with an expected increase in the demand of heated tobacco consumables
Altria has posted positive numbers for the last quarter of 2020 despite the coronavirus pandemic, with a good performance for its oral portfolio but unknown figures for Iqos in the US
Imperial Brands has announced a substantial shift in strategy towards its next-generation products category, with a focus on investment in heated tobacco in Europe over the next five years
Philip Morris International (PMI) is to have a new CEO, with Jacek Olczak taking over from André Calantzopoulos after the annual shareholder meeting in May
Apart from the obvious, what has 2020 brought us? And in particular, what has it brought to the world of alternative tobacco and tobacco alternatives?
British American Tobacco (BAT) is planning to invest up to $25m in a factory in Kenya to manufacture Lyft nicotine pouches – under regulatory scrutiny from officials in the country
The US Food and Drug Administration (FDA) has issued a marketing order authorising the sale of Philip Morris International (PMI)’s IQOS 3 holder and charger
Imperial Brands has revealed that net revenue from its next-generation portfolio declined by 27% in the year to September and announced that it will take a “more prudent approach” from now on
Altria’s oral tobacco portfolio drove the numbers of the Big Tobacco company, amid “uncertainties” caused by the COVID-19 pandemic
While Philip Morris International (PMI)’s earnings fell slightly in the third quarter of the year due to the ongoing COVID-19 challenges, shipments of the company’s heated tobacco units were up by 18.7%
Imperial Brands has revealed that the company’s net revenue for its next-generation portfolio is around 30% lower than 2019, while the overall company revenue looks set to remain flat this year
While the Philippines debates regulations to restrict tobacco alternatives, PMFTC, the Philippine affiliate of Philip Morris International (PMI), has opened its first four IQOS stores in the Manila area
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
KT&G heated tobacco products are available outside South Korea for the first time after Philip Morris International (PMI) began marketing them in Russia
Japan Tobacco International (JTI) is to increase the price of some of its heated tobacco consumables in Japan from 1st October
BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment
Altria has reported net revenue to be down by 3.8% in Q2 2020 due to the decrease of the traditional tobacco business, though a further drop was prevented thanks to the good performance of its smokeless products in the US
The Japanese Consumer Affairs Agency has imposed a fine of JPY552m ($5.1m) on Philip Morris Japan (PMJ) for misleading advertising of Iqos when discounts were extended beyond the allotted date
This report covers the US role as a modern oral tobacco product player, examining snus, tobacco-free nicotine pouches and all-free products
British American Tobacco (BAT) is pushing back to 2025 its goal of £5bn in revenues from its next-generation portfolio amid the COVID-19 pandemic and a decrease in heat-not-burn (HnB) business
The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
Japan Tobacco (JT) and Philip Morris International (PMI) are cutting the prices of their heat-not-burn (HnB) devices in Japan and planning new product launches amid the coronavirus pandemic
Altria has submitted premarket tobacco product applications (PMTAs) to the US Food and Drug Administration (FDA) for 35 varieties of its On! nicotine pouches
Big Tobacco manufacturers are expecting the effects of COVID-19 to hit hard in the second half of the year, despite a strong performance in the first quarter
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
British American Tobacco is suing Big Tobacco rival Philip Morris International in the US and in Europe for allegedly infringing its patents with its popular heated tobacco device IQOS
Philip Morris International is braced for a significant dip in sales and use of its heated-tobacco device IQOS over the rest of 2020, with retail and travel restrictions currently imposed in nearly every country
The US tobacco industry is resisting another attempt by the FDA to impose graphic health warnings, claiming in a lawsuit that mandatory warnings would violate their rights under the First Amendment
The US International Trade Commission (USITC) is looking into a possible infringement of the patent for a nicotine pouch product, following a claim led by Swedish Match North America
Philip Morris International (PMI)’s chief financial officer, Martin King, has been promoted to the newly created role of CEO for PMI America in a bid to further develop the company’s smoke-free segment
Swedish Match is to increase production of its tobacco-free nicotine pouch ZYN to 200m cans a year after a steep rise in demand in the US
British American Tobacco (BAT)’s “modern oral” portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9%
What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
